United States About Blog Lung Cancer Foundation of America blog is raising awareness and funds for the best
in lung cancer research.
This is a discounted rate that includes most non - MD / PhDs involved
in lung cancer research and treatment, including nurses, pharmacists, statisticians, respiratory therapists, patient advocates and all others interested in thoracic cancers.
Not exact matches
This appeared to be confirmed by further
research in 1954, prompting the government to issue its first warning of the link between
lung cancer and smoking.
Smoking
in cars can expose children's
lungs to levels of carcinogens and toxins at rates 10 times higher than when smoking was permitted
in bars, added Dr. Mark Travers, a
research scientist
in the Division of
Cancer Prevention and Population Sciences at Roswell.
Scientists from Moffitt reported
in the Jan. 19 online edition of
Cancer Research that nicotine induces the metastatic spread of lung cancer cells by stimulating a protein called beta - arresti
Cancer Research that nicotine induces the metastatic spread of
lung cancer cells by stimulating a protein called beta - arresti
cancer cells by stimulating a protein called beta - arrestin - 1.
After 20 years of
research and almost as many years fighting industry groups
in court for control of their data, government scientists can finally publish two papers showing that underground miners exposed to diesel fumes have a threefold increased risk for contracting
lung cancer.
Delegates included those interested
in all aspects of
lung cancer, including surgeons, medical oncologists, radiation oncologists, pulmonologists, radiologists, pathologists, epidemiologists, basic
research scientists, with special sessions for nurses, allied health professionals and advocacy members.
If hypofractionated radiation with curative intent can reduce the treatment time for
lung cancer patients by half with no greater toxicity, and with equivalent — if not better — tumor control and survival outcomes, this
research could result
in a change
in the paradigm of how a large subset of locally advanced NSCLC patients are treated.»
On the other hand, the continuing increase
in lung cancer mortality among European women represents a challenge for
cancer control, and the steady increase
in pancreatic
cancer deserves high priority for
research.»
The
research was published
in the Jan. 18 issue of Molecular Carcinogenesis, which focused on recent advances
in lung cancer.
While pursuing her project on how environmental contaminants and oxidative stress cause
lung cancer, Gelhaus complemented her postdoctoral training by spending some time with other PIs at Penn. «She has worked hard to develop skills that are independent of those available
in my own laboratory while working on a project that is central to my
research program,» Blair writes
in an e-mail to Science Careers.
The current
research suggests that pancreatic
cancer cells that spread to organs that receive a blood supply rich
in glucose and other nutrients, such as the liver and
lungs, acquire metabolic adaptations to use these «natural resources» to increase their tumorigenic fitness.
«This
research effort is important because it will assist
in recommending effective, optimal treatments tailored specifically to older patients with
lung cancer,» he said.
The trial also recorded fewer cases of
lung cancer in those on the treatment, consistent with basic
research findings hinting that the same inflammatory pathway may initiate or spur tumor growth.
Called the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) and funded by the drug giant Novartis, the trial also found fewer cases of
lung cancer in those on the treatment, rekindling basic
research findings hinting that the same inflammatory pathway may initiate or spur the growth of such tumors.
A drug approved by the Food and Drug Administration (FDA) for melanoma
in combination with a common cholesterol - lowering drug may show promise
in controlling
cancer growth
in patients with non-small cell
lung cancer (NSCLC), according to new
research from the Icahn School of Medicine at Mount Sinai.
Italian
researches have demonstrated a better way of determining the aggressiveness of tumors
in patients with advanced non-small cell
lung cancer (NSCLC).
Researchers at the Menzies Centre for Population Health
Research in Hobart have found that
in Tasmania between 1983 and 1992, there were almost twice as many
lung cancer cases among women aged between 25 and 44 years as
in men of the same age.
Terry Dwyer, director of the centre, says that more
research will be needed before the jump
in lung cancer in women under 45 can be blamed primarily on smoking.
New
research shows that microRNA - 486 is a potent tumor - suppressor molecule
in lung cancer, and that the it helps regulate the proliferation and migration of
lung -
cancer cells, and the induction of programmed cell death, or apoptosis,
in those cells.
Research from McMaster University has identified new regulators of brain metastases
in patients with
lung cancer.
«If you look at a set of
lung cancer patients, like we did in the paper, who develop brain metastases, they all have those two genes in their primary lung cancer,» said Sheila Singh, the study's supervisor, associate professor at the Michael G. DeGroote School of Medicine, scientist with the Stem Cell and Cancer Research Institute at McMaster University and neurosurgeon at McMaster Children's Hos
cancer patients, like we did
in the paper, who develop brain metastases, they all have those two genes
in their primary
lung cancer,» said Sheila Singh, the study's supervisor, associate professor at the Michael G. DeGroote School of Medicine, scientist with the Stem Cell and Cancer Research Institute at McMaster University and neurosurgeon at McMaster Children's Hos
cancer,» said Sheila Singh, the study's supervisor, associate professor at the Michael G. DeGroote School of Medicine, scientist with the Stem Cell and
Cancer Research Institute at McMaster University and neurosurgeon at McMaster Children's Hos
Cancer Research Institute at McMaster University and neurosurgeon at McMaster Children's Hospital.
Rhodes claims that
in his
research, the kit has had 85 percent accuracy
in identifying patients with
lung cancer.
Research at the school seeks new cures and treatments
in five key areas:
cancer, liver disease, heart /
lung disease, aging and brain disease, and infectious disease.
Severe health effects have been observed
in populations drinking arsenic - contaminated water over long periods, and
research has established that drinking water contaminated with arsenic causes skin
cancer and several internal
cancers such as
lung, bladder, and kidney
cancer, as well as cardiovascular disease and other adverse outcomes.
The
research, presented at the European Respiratory Society (ERS) International Congress
in Munich, suggests that testing the temperature of breath could be a simple and noninvasive method to either confirm or reject the presence of
lung cancer.
Lung cancer in particular has become the «poster child» for how
research and treatment have changed, says Charles Swanton, a
research oncologist at the Francis Crick Institute
in London, England.
Researchers from the University of Portsmouth's Brain Tumour
Research Centre of Excellence have identified molecules which are responsible for metastatic
lung cancer cells binding to blood vessels
in the brain.
The
research group plans to move forward with more - advanced technology and larger populations to investigate field cancerization
in other
lung cancer subtypes, such as small - cell
lung cancer,
in smokers and
in lung cancers that develop
in non-smokers.
Seemingly healthy cells may
in fact hide clues that
lung cancer will later develop, according to a study led by researchers at The University of Texas MD Anderson Cancer Center The research is published online in the Journal of the National Cancer Inst
cancer will later develop, according to a study led by researchers at The University of Texas MD Anderson
Cancer Center The research is published online in the Journal of the National Cancer Inst
Cancer Center The
research is published online
in the Journal of the National
Cancer Inst
Cancer Institute.
What's really impressive about Babar's accomplishment is that he did the work for both papers — one on the role of a population of stem cells
in lung cancer development (published
in Cell) the other on gene expression
in group A Streptococcus (published
in PNAS)-- as a participant
in summer undergraduate
research programs.
To investigate why checkpoint inhibitors so often stop working, Velculescu; Valsamo Anagnostou, M.D., Ph.D., instructor of oncology at the Johns Hopkins University School of Medicine; Kellie N. Smith, Ph.D., a
cancer immunology research associate at the Johns Hopkins University School of Medicine; and their colleagues at the Bloomberg ~ Kimmel Institute for Cancer Immunotherapy studied tumors of four patients with non-small cell lung cancer and one patient with head and neck cancer who developed resistance to two different checkpoint inhibitors: a drug called nivolumab that uses an antibody called anti-PD-1, or nivolumab used alone or in combination with a second drug called ipilimumab, which uses an antibody called anti-
cancer immunology
research associate at the Johns Hopkins University School of Medicine; and their colleagues at the Bloomberg ~ Kimmel Institute for
Cancer Immunotherapy studied tumors of four patients with non-small cell lung cancer and one patient with head and neck cancer who developed resistance to two different checkpoint inhibitors: a drug called nivolumab that uses an antibody called anti-PD-1, or nivolumab used alone or in combination with a second drug called ipilimumab, which uses an antibody called anti-
Cancer Immunotherapy studied tumors of four patients with non-small cell
lung cancer and one patient with head and neck cancer who developed resistance to two different checkpoint inhibitors: a drug called nivolumab that uses an antibody called anti-PD-1, or nivolumab used alone or in combination with a second drug called ipilimumab, which uses an antibody called anti-
cancer and one patient with head and neck
cancer who developed resistance to two different checkpoint inhibitors: a drug called nivolumab that uses an antibody called anti-PD-1, or nivolumab used alone or in combination with a second drug called ipilimumab, which uses an antibody called anti-
cancer who developed resistance to two different checkpoint inhibitors: a drug called nivolumab that uses an antibody called anti-PD-1, or nivolumab used alone or
in combination with a second drug called ipilimumab, which uses an antibody called anti-CTLA4.
Dr. Timmerman, who holds the Effie Marie Cain Distinguished Chair
in Cancer Therapy Research, has championed the use of SABR globally and has served as the lead investigator in several national trials designed to evaluate the efficacy and safety of SABR to treat cancer in the lung, liver, spine, and pro
Cancer Therapy
Research, has championed the use of SABR globally and has served as the lead investigator
in several national trials designed to evaluate the efficacy and safety of SABR to treat
cancer in the lung, liver, spine, and pro
cancer in the
lung, liver, spine, and prostate.
Scientists from the
Cancer Research UK Manchester Institute, based at The University of Manchester and part of the Manchester Cancer Research Centre, teamed up with experts at AstraZeneca, as part of a collaboration agreed in 2010, to test a drug — known as AZD3965 — on small cell lung cancer
Cancer Research UK Manchester Institute, based at The University of Manchester and part of the Manchester
Cancer Research Centre, teamed up with experts at AstraZeneca, as part of a collaboration agreed in 2010, to test a drug — known as AZD3965 — on small cell lung cancer
Cancer Research Centre, teamed up with experts at AstraZeneca, as part of a collaboration agreed
in 2010, to test a drug — known as AZD3965 — on small cell
lung cancer cancer cells.
The stem cells that proliferate the most
in response to damage caused by cigarette smoke repair their DNA using a process prone to errors, setting the stage for
lung cancer, according to a study publishing January 26, 2017
in the open - access journal PLOS Biology by Marie - Liesse Asselin - Labat and her team of the Walter and Eliza hall Institute of Medical
Research, Australia.
The article, titled «Entinostat Neutralizes Myeloid Derived Suppressor Cells and Enhances the Antitumor Effect of PD - 1 Inhibition
in Murine Models of
Lung and Renal Cell Carcinoma,» was published
in Clinical
Cancer Research and is available online.
The
research suggests that the genetic seeds of
cancer can sit dormant
in a person's
lungs for decades, providing hope that the disease could be detected early.
The study's findings, published
in the journal
Cancer Research, are the first to use these combined agents as an immune stimulator and may have the potential to kill cancerous cells
in solid tumors, including some of the most aggressive
cancers that form
in the
lung and pancreas.
Cancer Research UK scientists have found a drug combination that can trigger the self - destruct process in lung cancer cells — paving the way for new treatments, according to research that will be presented at the National Cancer Research Institute (NCRI) Cancer Conference in Live
Cancer Research UK scientists have found a drug combination that can trigger the self - destruct process in lung cancer cells — paving the way for new treatments, according to research that will be presented at the National Cancer Research Institute (NCRI) Cancer Conference in Li
Research UK scientists have found a drug combination that can trigger the self - destruct process
in lung cancer cells — paving the way for new treatments, according to research that will be presented at the National Cancer Research Institute (NCRI) Cancer Conference in Live
cancer cells — paving the way for new treatments, according to
research that will be presented at the National Cancer Research Institute (NCRI) Cancer Conference in Li
research that will be presented at the National
Cancer Research Institute (NCRI) Cancer Conference in Live
Cancer Research Institute (NCRI) Cancer Conference in Li
Research Institute (NCRI)
Cancer Conference in Live
Cancer Conference
in Liverpool.
The
Cancer Research UK team, based at the UCL Cancer Institute, has successfully fixed this fault in lung cancer cells — reprogramming the cells to self - des
Cancer Research UK team, based at the UCL
Cancer Institute, has successfully fixed this fault in lung cancer cells — reprogramming the cells to self - des
Cancer Institute, has successfully fixed this fault
in lung cancer cells — reprogramming the cells to self - des
cancer cells — reprogramming the cells to self - destruct.
«Advances
in lung cancer therapy require a greater understanding of the molecular origins of this deadly disease,» said last corresponding author Levantini, who is also a researcher at the Institute of Biomedical Technologies at the Italian National
Research Council (ITB - CNR).
Anil Potti, M.D., Duke University School of Medicine: Based on the reports of investigations conducted by Duke University School of Medicine (Duke) and additional analysis conducted by ORI
in its oversight review, ORI found that Dr. Anil Potti, former Associate Professor of Medicine, Duke, engaged
in research misconduct
in research supported by National Heart,
Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), grant R01 HL072208 and National
Cancer Institute (NCI), NIH, grants R01 CA136530, R01 CA131049, K12 CA100639, R01 CA106520, and U54 CA112952.
Researchers from the Perelman School of Medicine at the University of Pennsylvania, along with the Institute for Health
Research at Kaiser Permanente Colorado, Kaiser Permanente Hawaii, the Henry Ford Health System
in Detroit, and Marshfield Clinic Health System
in Wisconsin, have received a five - year, $ 15.5 million National
Cancer Institute (NCI) grant to improve lung cancer scre
Cancer Institute (NCI) grant to improve
lung cancer scre
cancer screening.
When a 2004 study by other researchers showed that eating foods containing beta - cryptoxanthin (BCX)-- a red pigment abundant
in sweet red peppers, paprika, winter and butternut squash, oranges, and tangerines, among other foods — was associated with a lower risk of
lung cancer in people who smoke, he made BCX a focus of his
research.
Rieger conducted her
research in zebrafish exposed to paclitaxel, a chemotherapeutic agent used for ovarian, breast,
lung, pancreatic and other
cancers.
The goal is to reward scientific excellence and to encourage innovative
research in lung cancer prevention and translational medicine.
Dr. Shepherd has been recognized for her many contributions
in the field of
lung cancer research.
Research Paper Hepatotoxicity
in Advanced
Lung Adenocarcinoma: A Retrospective Study of 2108 Cases Jie Qian, Xueyan Zhang, Bo Zhang, Ping Gu, Lin Wang, Baohui Han J.
Cancer 2018; 9 (9): 1607 - 1613.
Short
Research Communication The Factors Reducing Relative Dose Intensity of Cisplatin and Vinorelbine as Adjuvant Chemotherapy
in Patients with Non-Small Cell
Lung Cancer Ryo Inose, Katsuyuki Takahashi, Naruo Yoshimura, Tomoya Kawaguchi, Mitsutaka Takada, Katsuya Nagayama Oncomedicine 2018; 3: 9 - 14.
Our current efforts
in the AST - VAC2 program are focused on progressing this product towards a Phase 1 / 2a clinical trial
in non-small cell
lung cancer in collaboration with Cancer Research UK (
cancer in collaboration with
Cancer Research UK (
Cancer Research UK (CRUK).